Simple and Robust Detection of <i>CYP2D6</i> Gene Deletions and Duplications Using <i>CYP2D8P</i> as Reference
Genotyping of the <i>CYP2D6</i> gene is the most commonly applied pharmacogenetic test globally. Significant economic interests have led to the development of a plurality of assays, available for almost any genotyping platform or DNA detection chemistry. Of all the genetic variants, copy...
Glavni autori: | Jens Borggaard Larsen, Steffen Jørgensen |
---|---|
Format: | Članak |
Jezik: | English |
Izdano: |
MDPI AG
2022-01-01
|
Serija: | Pharmaceuticals |
Teme: | |
Online pristup: | https://www.mdpi.com/1424-8247/15/2/166 |
Slični predmeti
-
Afro-Latin American Pharmacogenetics of <i>CYP2D6</i>, <i>CYP2C9</i>, and <i>CYP2C19</i> in Dominicans: A Study from the RIBEF-CEIBA Consortium
od: Mariela Guevara, i dr.
Izdano: (2024-10-01) -
An Investigational Study on the Role of <i>CYP2D6</i>, <i>CYP3A4</i> and <i>UGT</i>s Genetic Variation on Fesoterodine Pharmacokinetics in Young Healthy Volunteers
od: Andrea Rodríguez-Lopez, i dr.
Izdano: (2024-09-01) -
Association of <i>CYP2C19, CYP2D6</i> and <i>CYP3A4</i> Genetic Variants on Primaquine Hemolysis in G6PD-Deficient Patients
od: Marielle M. Macêdo, i dr.
Izdano: (2023-06-01) -
<i>CYP2D6</i> Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis
od: Pura Ballester, i dr.
Izdano: (2023-07-01) -
Genetic Variation in <i>CYP2D6</i>, <i>UGT1A4</i>, <i>SLC6A2</i> and <i>SLCO1B1</i> Alters the Pharmacokinetics and Safety of Mirabegron
od: Paula Soria-Chacartegui, i dr.
Izdano: (2024-08-01)